Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.

Elshafei, Mohamed Nabil; El-Bardissy, Ahmed; Khalil, Ahmed; Danjuma, Mohammed; Mubasher, Mahmood; Abubeker, Ibrahim Y; Mohamed, Mouhand F H

Elshafei, Mohamed Nabil; El-Bardissy, Ahmed; Khalil, Ahmed; Danjuma, Mohammed; Mubasher, Mahmood; Abubeker, Ibrahim Y; Mohamed, Mouhand F H.

Afiliação

Elshafei MN; Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.
El-Bardissy A; Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Khalil A; Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Danjuma M; College of Medicine, Qatar University, Doha, Qatar.
Mubasher M; Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Abubeker IY; Department of Internal Medicine, Rochester Regional Health, Unity Hospital of Rochester, Rochester, NY, USA.
Mohamed MFH; Alpert Medical School, Brown University, Providence, RI, USA.

Eur J Clin Invest ; 51(9): e13645, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34185313

Assuntos

Tratamento Farmacológico da COVID-19; Colchicina/uso terapêutico; Moduladores de Tubulina/uso terapêutico; COVID-19/mortalidade; Humanos; Razão de Chances; SARS-CoV-2

Palavras-chave

COVID-19; SARS-CoV-2; colchicine; coronavirus disease 2019; mortality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colchicina / Moduladores de Tubulina / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google